Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
10 2019
Historique:
received: 11 03 2019
revised: 20 06 2019
accepted: 01 07 2019
pubmed: 10 7 2019
medline: 13 8 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

Altered expression of XPO1, the main nuclear export receptor in eukaryotic cells, has been observed in cancer, and XPO1 has been a focus of anticancer drug development. However, mechanistic evidence for cancer-specific alterations in XPO1 function is lacking. Here, genomic analysis of 42,793 cancers identified recurrent and previously unrecognized mutational hotspots in

Identifiants

pubmed: 31285298
pii: 2159-8290.CD-19-0298
doi: 10.1158/2159-8290.CD-19-0298
pmc: PMC6774834
mid: NIHMS1533928
doi:

Substances chimiques

Karyopherins 0
Nuclear Export Signals 0
Receptors, Cytoplasmic and Nuclear 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1452-1467

Subventions

Organisme : NIH HHS
ID : U54 OD020355
Pays : United States
Organisme : NCI NIH HHS
ID : K08 CA230319
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207244
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA201247
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128239
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA218896
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI079087
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130724
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204749
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2019 American Association for Cancer Research.

Références

Curr Biol. 2015 Oct 19;25(20):2663-71
pubmed: 26441354
Elife. 2015 Dec 17;4:
pubmed: 26673895
Cancer Cell. 2018 Sep 10;34(3):499-512.e9
pubmed: 30205049
Blood. 2017 Jun 15;129(24):3165-3174
pubmed: 28336527
Blood. 2013 Oct 24;122(17):3034-44
pubmed: 23970380
Br J Haematol. 2019 Jun;185(5):852-864
pubmed: 30924136
Nat Biotechnol. 2016 Feb;34(2):155-63
pubmed: 26619011
N Engl J Med. 2005 Apr 28;352(17):1819-20; author reply 1819-20
pubmed: 15858195
J Clin Oncol. 2016 Dec;34(34):4142-4150
pubmed: 26926685
Nature. 1985 Dec 12-18;318(6046):533-8
pubmed: 3906410
Science. 2015 Nov 27;350(6264):1092-6
pubmed: 26472760
Science. 2015 Nov 27;350(6264):1096-101
pubmed: 26472758
Blood. 2018 Dec 13;132(24):2546-2554
pubmed: 30352784
Nat Struct Mol Biol. 2010 Nov;17(11):1367-76
pubmed: 20972448
Dev Biol. 2002 Apr 15;244(2):305-18
pubmed: 11944939
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9112-7
pubmed: 10430904
Blood. 2017 Oct 5;130(14):1644-1648
pubmed: 28801450
Mol Cell Proteomics. 2013 Mar;12(3):664-78
pubmed: 23242554
Nucleic Acids Res. 2017 Mar 17;45(5):2644-2657
pubmed: 28158555
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14943-8
pubmed: 10611317
Blood. 2017 Jun 15;129(24):3175-3183
pubmed: 28468797
J Biol Chem. 2000 Dec 8;275(49):38589-96
pubmed: 10991937
Science. 1995 Sep 8;269(5229):1427-9
pubmed: 7660125
Oncogene. 2006 Jul 20;25(31):4376-80
pubmed: 16501600
Exp Cell Res. 2000 Apr 10;256(1):213-24
pubmed: 10739668
Cancer Cell. 2011 Jul 12;20(1):11-24
pubmed: 21723200
Cell. 1997 Sep 19;90(6):1051-60
pubmed: 9323133
Nature. 1997 Nov 20;390(6657):308-11
pubmed: 9384386
Cell. 1997 Sep 19;90(6):1041-50
pubmed: 9323132
Nature. 2011 Jun 05;475(7354):101-5
pubmed: 21642962
Bioinformatics. 2014 May 1;30(9):1220-7
pubmed: 24413524
Nat Struct Mol Biol. 2013 Oct;20(10):1191-8
pubmed: 24013206
J Clin Oncol. 2016 Sep 10;34(26):3166-74
pubmed: 27458288
Mol Cell Biol. 1999 Feb;19(2):1486-97
pubmed: 9891082
Cancer Res. 2013 Jul 1;73(13):3821-32
pubmed: 23639940
Nat Genet. 2014 May;46(5):467-73
pubmed: 24686850
Science. 1997 Oct 3;278(5335):141-4
pubmed: 9311922
Int J Cancer. 1979 Feb;23(2):174-80
pubmed: 83966
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Nature. 2009 Apr 30;458(7242):1136-41
pubmed: 19339969
Leukemia. 2013 Dec;27(12):2357-65
pubmed: 23752175
Elife. 2017 Mar 10;6:
pubmed: 28282025
Cell Mol Life Sci. 2016 Dec;73(24):4685-4699
pubmed: 27312238
Science. 2009 May 22;324(5930):1087-91
pubmed: 19389996
Blood. 2013 May 16;121(20):4166-74
pubmed: 23564911
EMBO J. 1999 Mar 15;18(6):1660-72
pubmed: 10075936
Cell. 2013 Feb 14;152(4):714-26
pubmed: 23415222
Cancer Discov. 2018 Feb;8(2):174-183
pubmed: 29247016
Haematologica. 2016 Sep;101(9):1094-101
pubmed: 27479820
J Clin Oncol. 2016 Dec;34(34):4094-4101
pubmed: 27507877

Auteurs

Justin Taylor (J)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Maria Sendino (M)

Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Barrio Sarriena s/n, Leioa, Spain.

Alexander N Gorelick (AN)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Alessandro Pastore (A)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Matthew T Chang (MT)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Alexander V Penson (AV)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Elena I Gavrila (EI)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Connor Stewart (C)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Ella M Melnik (EM)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Florisela Herrejon Chavez (F)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Lillian Bitner (L)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Akihide Yoshimi (A)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Stanley Chun-Wei Lee (SC)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Daichi Inoue (D)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Bo Liu (B)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Xiao J Zhang (XJ)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Anthony R Mato (AR)

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Ahmet Dogan (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

Michael G Kharas (MG)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

Yuhong Chen (Y)

Blood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin.

Demin Wang (D)

Blood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin.

Rajesh K Soni (RK)

Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.

Ronald C Hendrickson (RC)

Microchemistry and Proteomics Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.

Gorka Prieto (G)

Department of Communications Engineering, University of the Basque Country (UPV/EHU), Bilbao, Spain.

Jose A Rodriguez (JA)

Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Barrio Sarriena s/n, Leioa, Spain.

Barry S Taylor (BS)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Omar Abdel-Wahab (O)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. abdelwao@mskcc.org.
Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH